EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Orange lungs on yellow background

AstraZeneca supports first asthma and COPD breakthrough in 50 years

Research supported by AstraZeneca has demonstrated that a single dose of benralizumab significantly reduces treatment failure rates – by four times compared to traditional steroid tablets.

Donald Trump picks last role in health leadership team

President-elect Donald Trump has picked the final post in his health team, selecting Dr Jay Bhattacharya to be Director of the US National Institutes of Health.

Europe's biopharma SMEs need urgent support, warns EFPIA

Europe must act urgently to back small and medium-sized enterprises (SMEs) in the biopharmaceutical sector, says the EFPIA.

First anti-TFPI for haemophilia approved in EU

Pfizer’s anti-tissue factor pathway inhibitor has been approved for the treatment of haemophilia A & B by the European Commission.
Handshake on blue background

FDA greenlights UCB’s IL-17 inhibitor for HS

The novel IL-17A and IL-17F inhibitor has been approved the treatment of moderate to severe hidradenitis suppurativa, a chronic and painful skin disease.
world in hands

Novartis takes the top spot in 2024 Access to Medicine Index

Novartis has claimed the top spot in the 2024 Access to Medicine Index, displacing GSK after 16 consecutive years at the top.  

Revisto raises $4m to streamline pharma compliance with AI

Revisto has raised $4m in seed funding to simplify the pharmaceutical industry’s marketing compliance processes using AI.
stamp of approval

FDA approves first gene therapy delivered directly to the brain

Discover how PTC Therapeutics’ treatment for a rare and fatal genetic disorder called aromatic l-amino acid decarboxylase (AADC) deficiency reached approval